| Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer JM Jiménez-Vacas, V Herrero-Aguayo, AJ Montero-Hidalgo, ... EBioMedicine 51, 2020 | 81 | 2020 |
| Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer JM Jiménez-Vacas, V Herrero-Aguayo, E Gómez-Gómez, ... Translational Research 212, 89-103, 2019 | 64 | 2019 |
| Dysregulation of the splicing machinery is associated to the development of nonalcoholic fatty liver disease M del Río-Moreno, E Alors-Pérez, S González-Rubio, G Ferrín, O Reyes, ... The Journal of Clinical Endocrinology & Metabolism 104 (8), 3389-3402, 2019 | 62 | 2019 |
| Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors S Pedraza-Arévalo, MD Gahete, E Alors-Pérez, RM Luque, JP Castaño Reviews in Endocrine and Metabolic Disorders 19, 179-192, 2018 | 39 | 2018 |
| Changes in splicing machinery components influence, precede, and early predict the development of type 2 diabetes: from the CORDIOPREV study MD Gahete, M del Rio-Moreno, A Camargo, JF Alcala-Diaz, E Alors-Perez, ... EBioMedicine 37, 356-365, 2018 | 38 | 2018 |
| Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug E Alors-Perez, R Blázquez-Encinas, S Alcalá, C Viyuela-García, ... Journal of Experimental & Clinical Cancer Research 40, 1-21, 2021 | 28 | 2021 |
| Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell types M del Rio-Moreno, E Alors-Perez, PB de Souza, ME Prados-Gonzalez, ... Translational Research 211, 147-160, 2019 | 25 | 2019 |
| Mouse models of endocrine tumors MD Gahete, JM Jimenez-Vacas, E Alors-Perez, V Herrero-Aguayo, ... Journal of Endocrinology 240 (3), R73-R96, 2019 | 13 | 2019 |
| Dietary intervention modulates the expression of splicing machinery in cardiovascular patients at high risk of type 2 diabetes development: from the CORDIOPREV study M del Río-Moreno, RM Luque, OA Rangel-Zúñiga, E Alors-Pérez, ... Nutrients 12 (11), 3528, 2020 | 10 | 2020 |
| Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors S Pedraza-Arevalo, E Alors-Pérez, R Blázquez-Encinas, ... Translational Research 251, 63-73, 2023 | 9 | 2023 |
| Ghrelin-O-acyltransferase (GOAT) enzyme as a novel potential biomarker in gastroenteropancreatic neuroendocrine tumors AD Herrera-Martínez, MD Gahete, R Sánchez-Sánchez, E Alors-Perez, ... Clinical and Translational Gastroenterology 9 (10), e196, 2018 | 9 | 2018 |
| The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities R Blázquez-Encinas, MT Moreno-Montilla, V García-Vioque, ... Reviews in Endocrine and Metabolic Disorders 24 (2), 267-282, 2023 | 7 | 2023 |
| Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing JL López‐Cánovas, N Hermán‐Sánchez, MT Moreno‐Montilla, ... Clinical and Translational Medicine 12 (11), e1102, 2022 | 6 | 2022 |
| Molecular and clinical implications of somatostatin receptor profile and somatostatin analogues treatment in oral cavity squamous cell carcinoma A Sanjuan-Sanjuan, E Alors-Perez, M Sanchez-Frías, A Dean-Ferrer, ... Cancers 13 (19), 4828, 2021 | 6 | 2021 |
| Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBioMedicine 51 102547 JM Jiménez-Vacas, V Herrero-Aguayo, AJ Montero-Hidalgo, ... | 6 | 2020 |
| Cytokines and lymphoid populations as potential biomarkers in locally and borderline pancreatic adenocarcinoma I González-Borja, A Viúdez, E Alors-Pérez, S Goñi, I Amat, I Ghanem, ... Cancers 14 (23), 5993, 2022 | 2 | 2022 |
| Unveiling the role and contribution of CELF4 to the malignant features of PanNETs VG Vioque, E Alors-Perez, SP Arevalo, A Agraz-Doblas, ... Endocrine Abstracts 81, 2022 | 1 | 2022 |
| Deciphering Chfr role in pancreatic ductal adenocarcinoma I González-Borja, E Alors-Pérez, I Amat, L Alonso, C Viyuela-García, ... Frontiers in medicine 8, 720128, 2021 | 1 | 2021 |
| Obesity is associated with a dysregulation in the splicing machinery components at the hepatic level: influence of metformin L Fernando, E Alors-Perez, A Sarmento-Cabral, JP Castano, RM Luque, ... Endocrine Abstracts 56, 2018 | 1 | 2018 |
| Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response E Alors-Pérez, S Pedraza-Arevalo, R Blázquez-Encinas, V García-Vioque, ... Molecular Therapy-Nucleic Acids 35 (1), 2024 | | 2024 |
